Last April, the US National Science Advisory Board for Biosecurity issued a draft report on Biosecurity (see post below). One point of criticism expressed with regard to this report was that it did not address explicitly concerns specific to synthetic biology.

In a Commentary published in Nature Biotechnology (Bügl et al, 2007), a panel of scientists, executives from the DNA-synthesis industry and members of the US FBI present now their views and concrete recommendations on measures required for an efficient and practical oversight of DNA-synthesis activities.

Read more…